North America Digital Pathology Market

The digital pathology market in North America is expected to grow from US$ 361.14 million in 2022 to US$ 733.30 million by 2028. It is estimated to grow at a CAGR of 12.5% from 2022 to 2028. 

Technological Advancements in Digital Pathology Systems Drives Growth of Digital Pathology Market in North America

Computerization, robotic light microscopy, multiple fiber-optic communications, and digital imaging are among the technologies contributing to the modernization of digital pathology. Healthcare information technology (IT) helps physicians in maintaining optimal workflow, along with allowing them to meet the continuously changing patient expectations. The Aperio ePathAccess software offered by Leica Biosystems enables users to share digital pathology images and case data with experts outside the IT network. Further, frequent advancements in whole-slide imaging (WSI) technology, software applications, LIS/LIMS interface, and high-speed networking are allowing pathologists to fully integrate digital pathology into their workflows. Further, the growing use of microarrays and predictive models, such as API algorithms and hybrid models, is bolstering the demand for digital image analysis. A computer-aided diagnosis integrates image processing with the concepts of physics and mathematics, and computational algorithms for disease diagnosis, anatomical evaluation, and disease progression quantification and risk assessment. Thus, the increasing popularity of computer-aided systems is supporting the digital pathology market growth in North America. 

Market Overview 

The North America digital pathology market is segmented into the US, Canada, and Mexico. North America held the largest share of the global market in 2022 owing to the growing initiatives to promote digital pathology as a tool for enhanced disease diagnosis and advanced pathology practice. Furthermore, organizations strive to promote digital pathology by spreading awareness about practicalities and strategies adopted for proper implementation and improvement of pathology workflows. FDA has cleared the use of digital pathology and whole slide imaging (WSI) system in primary diagnosis. In April 2017, first WSI system for digital pathology was allowed for primary diagnostic use in the US. This has helped pathologists to digitize the workflow and gather, store, and transfer patent’s data from remote places. A second system was authorized for marketing in the US in 2019. As a result, 100% of labs in the US are likely to go digital in the future. Many industry players are focusing on the digitization of pathology labs. Approval of WSI systems by the US FDA has enabled research institutes in the US to increase their efficiency and workflow. Thus, the increase in cancer cases in the US, benefits of digital pathology solutions, and cost and time reduction in pathology procedures are among the factors expected to drive the growth of the digital pathology systems market in the US during the forecast period. 

North America Digital Pathology Market Revenue and Forecast to 2028 (US$ Million) 

North America Digital Pathology Strategic Insights

Strategic insights for the North America Digital Pathology provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Digital Pathology Report Scope

North America Digital Pathology Regional Insights

The geographic scope of the North America Digital Pathology refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.